World Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

World Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$332K	Sell	2,549 -20	-0.8%	-$3.02K	0.03%	565
2021 Q2	$456K	Buy	2,569 +48	+2%	+$8.31K	0.04%	463
2021 Q1	$414K	Sell	2,521 -110	-4%	-$18.1K	0.04%	521
2020 Q4	$434K	Sell	2,631 -127	-5%	-$18.9K	0.04%	453
2020 Q3	$393K	Buy	+2,758	New	+$342K	0.04%	439
2020 Q1	–	Sell	-1,528	Closed	-$228K	–	1001
2019 Q4	$228K	Sell	1,528 -264	-15%	-$35.9K	0.01%	921
2019 Q3	$230K	Buy	1,792 +24	+1%	+$3.22K	0.01%	966
2019 Q2	$252K	Sell	1,768 -97	-5%	-$13K	0.01%	938
2019 Q1	$267K	Sell	1,865 -97	-5%	-$12.7K	0.01%	900
2018 Q4	$243K	Sell	1,962 -99	-5%	-$14.7K	0.02%	855
2018 Q3	$347K	Buy	2,061 +14	+0.7%	+$2.41K	0.02%	867
2018 Q2	$353K	Buy	+2,047	New	+$335K	0.02%	873
2017 Q4	–	Sell	-1,451	Closed	-$212K	–	1516
2017 Q3	$212K	Buy	1,451 +10	+0.7%	+$1.51K	0.01%	1353
2017 Q2	$224K	Buy	1,441 +27	+2%	+$4.13K	0.01%	1282
2017 Q1	$205K	Buy	+1,414	New	+$184K	0.01%	1283
2016 Q4	–	Sell	-1,667	Closed	-$203K	–	1388
2016 Q3	$203K	Buy	1,667 +217	+15%	+$29.3K	0.01%	1259
2016 Q2	$205K	Buy	+1,450	New	+$214K	0.01%	1088
2015 Q3	–	Sell	-1,287	Closed	-$227K	–	1189
2015 Q2	$227K	Sell	1,287 -629	-33%	-$113K	0.01%	987
2015 Q1	$331K	Sell	1,916 -74	-4%	-$12.7K	0.01%	1023
2014 Q4	$326K	Sell	1,990 -721	-27%	-$120K	0.01%	1033
2014 Q3	$435K	Buy	2,711 +7	+0.3%	+$1.08K	0.01%	941
2014 Q2	$398K	Buy	2,704 +108	+4%	+$15K	0.01%	1036
2014 Q1	$360K	Sell	2,596 -39	-1%	-$5.87K	0.01%	1083
2013 Q4	$333K	Sell	2,635 -1,362	-34%	-$141K	0.01%	1135
2013 Q3	$368K	Sell	3,997 -637	-14%	-$51.4K	0.01%	1172
2013 Q2	$318K	Buy	+4,634	New	+$283K	0.01%	1278

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

World Asset Management's JAZZ Position: Q3 2021 in Review

World Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.78% in Q3 2021, selling an estimated $3.02K and leaving 2,549 shares worth $332K. The position accounts for 0.03% of the portfolio, ranked #565.

World Asset Management first reported a position in JAZZ in Q2 2013 and has held it in 26 quarters since. The position peaked at $456K in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

World Asset Management held 2,549 shares of Jazz Pharmaceuticals worth $332K as of Q3 2021.
World Asset Management sold 20 Jazz Pharmaceuticals shares in Q3 2021, an estimated $3.02K.
Jazz Pharmaceuticals made up 0.03% of World Asset Management's portfolio in Q3 2021, its #565 holding.
World Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 26 quarters since.
World Asset Management's Jazz Pharmaceuticals position peaked at $456K in Q2 2021.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.